🇺🇸 Anastrazole (Arimidex) in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Anastrazole (Arimidex) on 5 December 2008

Marketing authorisation

FDA — authorised 5 December 2008

Application: NDA022214
Marketing authorisation holder: ASTRAZENECA
Local brand name: ARIMIDEX
Indication: TABLET — ORAL
Status: approved

Read official source →

Other Oncology approved in United States

Frequently asked questions

Is Anastrazole (Arimidex) approved in United States?

Yes. FDA authorised it on 5 December 2008.

Who is the marketing authorisation holder for Anastrazole (Arimidex) in United States?

ASTRAZENECA holds the US marketing authorisation.